Kyle Guse
2014
In 2014, Kyle Guse earned a total compensation of $746.2K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,625 |
|---|---|
| Option Awards | $236,190 |
| Salary | $350,000 |
| Other | $10,400 |
| Total | $746,215 |
Guse received $350K in salary, accounting for 47% of the total pay in 2014.
Guse also received $149.6K in non-equity incentive plan, $236.2K in option awards and $10.4K in other compensation.
Rankings
In 2014, Kyle Guse's compensation ranked 8,801st out of 13,032 executives tracked by ExecPay. In other words, Guse earned more than 32.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,801 out of 13,032 | 33rd |
Division Manufacturing | 3,281 out of 4,965 | 34th |
Major group Chemicals And Allied Products | 1,115 out of 1,690 | 34th |
Industry group Drugs | 889 out of 1,369 | 35th |
Industry Pharmaceutical Preparations | 678 out of 1,042 | 35th |
Source: SEC filing on April 13, 2016.
Guse's colleagues
We found four more compensation records of executives who worked with Kyle Guse at Atossa Genetics in 2014.
2014
Steven Quay
Atossa Genetics
Chief Executive Officer
2014
Christopher Destro
Atossa Genetics
Senior Vice President of Sales and Marketing
2014
John Sawyer
Atossa Genetics
Senior Vice President of Regulatory Affairs and Quality Assurance
2014
Scott Youmans
Atossa Genetics
Chief Operating Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019